194 related articles for article (PubMed ID: 29705848)
1. How to Monitor the Neuroimmune Biological Response in Patients Affected by Immune Alteration-Related Systemic Diseases.
Lissoni P; Rovelli F; Vigorè L; Messina G; Lissoni A; Porro G; Di Fede G
Methods Mol Biol; 2018; 1781():171-191. PubMed ID: 29705848
[TBL] [Abstract][Full Text] [Related]
2. A reinterpretation of the pathogenesis and cure of cancer according to the psychoneuroimmunological discoveries.
Lissoni P
Methods Mol Biol; 2012; 934():183-92. PubMed ID: 22933147
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patients.
Lissoni P; Rovelli F; Giani L; Fumagalli L; Mandalà M
Nat Immun; 1998; 16(5-6):178-84. PubMed ID: 11061586
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine dysfunction in Sjogren's syndrome.
Tzioufas AG; Tsonis J; Moutsopoulos HM
Neuroimmunomodulation; 2008; 15(1):37-45. PubMed ID: 18667798
[TBL] [Abstract][Full Text] [Related]
5. Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systems.
Lissoni P; Messina G; Brivio F; Rovelli F; Di Fede G; Mainini E; Veronese E
J Biol Regul Homeost Agents; 2005; 19(3-4):141-4. PubMed ID: 16602629
[TBL] [Abstract][Full Text] [Related]
6. [Is the immune system our sixth sense? Relation between the immune and neuroendocrine systems].
Ferencík M; Stvrtinová V
Bratisl Lek Listy; 1997 Apr; 98(4):187-98. PubMed ID: 9264825
[TBL] [Abstract][Full Text] [Related]
7. Intersections Between Neuroimmune and Microbiota.
Ngo Ndjom CG; Gonzalez XF; Jones HP
Methods Mol Biol; 2018; 1781():21-35. PubMed ID: 29705840
[TBL] [Abstract][Full Text] [Related]
8. Altered time structure of neuro-endocrine-immune system function in lung cancer patients.
Mazzoccoli G; Vendemiale G; De Cata A; Carughi S; Tarquini R
BMC Cancer; 2010 Jun; 10():314. PubMed ID: 20565977
[TBL] [Abstract][Full Text] [Related]
9. Modulation of anticancer cytokines IL-2 and IL-12 by melatonin and the other pineal indoles 5-methoxytryptamine and 5-methoxytryptophol in the treatment of human neoplasms.
Lissoni P
Ann N Y Acad Sci; 2000; 917():560-7. PubMed ID: 11268384
[TBL] [Abstract][Full Text] [Related]
10. Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment.
Cutolo M; Straub RH
Arthritis Res Ther; 2009; 11(2):218. PubMed ID: 19435479
[TBL] [Abstract][Full Text] [Related]
11. The immune-pineal axis: a shuttle between endocrine and paracrine melatonin sources.
Markus RP; Ferreira ZS; Fernandes PA; Cecon E
Neuroimmunomodulation; 2007; 14(3-4):126-33. PubMed ID: 18073503
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine-immune system interactions and autoimmunity.
Wilder RL
Annu Rev Immunol; 1995; 13():307-38. PubMed ID: 7612226
[TBL] [Abstract][Full Text] [Related]
13. The pineal gland as a central regulator of cytokine network.
Lissoni P
Neuro Endocrinol Lett; 1999; 20(6):343-349. PubMed ID: 11458197
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression.
Woiciechowsky C; Schöning B; Lanksch WR; Volk HD; Döcke WD
J Mol Med (Berl); 1999 Nov; 77(11):769-80. PubMed ID: 10619437
[TBL] [Abstract][Full Text] [Related]
15. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases.
Calcagni E; Elenkov I
Ann N Y Acad Sci; 2006 Jun; 1069():62-76. PubMed ID: 16855135
[TBL] [Abstract][Full Text] [Related]
16. Cytokine dysregulation, inflammation and well-being.
Elenkov IJ; Iezzoni DG; Daly A; Harris AG; Chrousos GP
Neuroimmunomodulation; 2005; 12(5):255-69. PubMed ID: 16166805
[TBL] [Abstract][Full Text] [Related]
17. Anticancer neuroimmunomodulation by pineal hormones other than melatonin: preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatonin.
Lissoni P; Fumagalli L; Paolorossi F; Rovelli F; Roselli MG; Maestroni GJ
J Biol Regul Homeost Agents; 1997; 11(3):119-22. PubMed ID: 9498162
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine modulation of cancer progression.
Armaiz-Pena GN; Lutgendorf SK; Cole SW; Sood AK
Brain Behav Immun; 2009 Jan; 23(1):10-5. PubMed ID: 18638541
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6: a cytokine and/or a major modulator of the response to somatic stress.
Mastorakos G; Ilias I
Ann N Y Acad Sci; 2006 Nov; 1088():373-81. PubMed ID: 17192581
[TBL] [Abstract][Full Text] [Related]
20. The psychoneuroendocrine-immunotherapy of cancer: Historical evolution and clinical results.
Lissoni P; Messina G; Lissoni A; Franco R
J Res Med Sci; 2017; 22():45. PubMed ID: 28567065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
